ImetelChat

In 2018 when I first started investing in Geron the life expectancy after jak failure was 7-12 months - now the jak timing has changed complicating everything - the histology will be so critical and hopefully the Mayo Clinic’s original excitement over fibrosis reversal is evident

I was just coming to post that article I saw on Twitter

it has been a much longer road than i ever expected - i feel the delay in a european partner/launch is because the plan is to sell and that will happen after the interim analysis - histology will be immensely important

thanks for all you do - getting frustrating and losing interest - we could really use some good news

PLATZBECKER, Uwe
ADÈS, Lionel Jean
LANE, Steven William

We all recognize a couple of the names listed as “inventors”

that looks great - wasn't feeling great with the stock price dropping so much - do not think we can handle anymore good news

Very disappointing after the news report we saw in Australia

thanks for the information - I think everyone has grown tired of this study and would like a positive end soon - don't know if i can take 2 more years

I feel they are being conservative in what they say to avoid litigation, but if the interim analysis is strong, and another key will be the pathology and if they show bone marrow fibrosis reversal that I could see them getting an early approval

back when Scarlet was in charge
-Geron said if the interim phase 3 data was strong they would apply for approval based off that
- Scarlet also said he felt the phase 3 data had good chance to be better than phase 2 because they learned who the responders would be

https://youtu.be/el2Yvu0jU3k?si=IN_0HK0eShL_2l6Q

We will see if the response is dose dependent in phase 3 with the two arms

1.83 - and I bet you’re gonna see that a lot more shorts have cleared out

if they wanted a partner it would of been done by now - and should of been done by now - they are waiting for the interim analysis and hoping it is strong to make the final move

Up to 1.61 with another 15 million of volume - historically the price usually tanks around now and then everyone got their options before the price rises before the shareholder meeting

I have always felt we have not seen a partner yet because they want to get the MF interim analysis - and if strong - will sell unencumbered - if they bring a partner in now for MDS in Europe, it just muddy the waters

No, it’s a legit email from them - years ago I registered with them to receive updates and they were sending me an email tonight to confirm that that email address is still good.

I just got an email from Geron confirming my email address - is there a plan for an important notification? never happened before

We are up to 1.53 now - Friday someone bought some big chunks

- someone know something - European partner? Impact ready for interim analysis ?